共 122 条
[1]
Freifeld AG(2011)Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America Clin Infect Dis 52 e56-e93
[2]
Bow EJ(2013)A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia J Med Econ 16 720-735
[3]
Sepkowitz KA(2004)Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management Cancer. 100 228-237
[4]
Boeckh MJ(2015)Results of high-risk neutropenia therapy of hematology-oncology patients in a university hospital in Uruguay Rev Bras Hematol Hemoter 37 28-33
[5]
Ito JI(2004)Management of fever in neutropenic patients with different risks of complications Clin Infect Dis 39 S32-S37
[6]
Mullen CA(2014)Time to antibiotics and outcomes in cancer patients with febrile neutropenia BMC Health Serv Res 14 162-198
[7]
Raad II(2014)Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings J Oncol Pharm Pract 20 190-913
[8]
Rolston KV(2016)Prevention and treatment of cancer-related infections, version 2.2016, NCCN clinical practice guidelines in oncology J Natl Compr Cancer Netw 14 882-1453
[9]
Young JA(2018)Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update J Clin Oncol 36 1443-2266
[10]
Wingard JR(2006)Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients Cancer. 106 2258-ee61